CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Executive VP, Head of R&D sold 7,158 shares at an average $75.04 ($537,123)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 17,275 shares at an average $64.68 ($1,117,266)
- 4 Open-market sale President sold 50,000 shares at an average $70.20 ($3,510,020)
- 4 Open-market sale Executive VP, Head of R&D sold 6,700 shares at an average $70.13 ($469,884)
- 4 Open-market sale President sold 50,000 shares at $65.00 ($3,250,000)
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $65.25 ($978,683)
- 4 Open-market sale CBO & COO sold 25,000 shares at an average $60.40 ($1,509,971)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 1,563 shares (to pay taxes)
Page 15 of 26 · 502 filings